Medtech product development & consulting
Medtech trends 2025
SURGICAL MINIATURISATION
Women's health
SUSTAINABLE DIAGNOSTICS
CTOs, R&D leaders, and investors trust us with their most business-critical medical technology developments, partnering to maximise value creation from technology investments and defining winning R&D strategy. Typically, this includes proof-of-concept cutting-edge products that must be safe and easy to use, and rapid system development through to regulatory approval and transfer to manufacture.
Arrange a meeting
We'd be delighted to listen to your business challenges and objectives to explore the ways in which we can support you and your team.
Case studies of medical R&D projects we can talk about:
Why partner with Sagentia Innovation for your medical R&D?
"From first engagements to multi-year programmes, we work closely with our clients, building long term relationships rooted in technical trust and market understanding. Whether we are working with top 10 medtechs or ambitious PE or VC backed startups, clients like working with us because we are large enough to have all the skills and experience required, but not a huge corporate where they are just another client."
Duncan Smith, SVP, Managing Partner, Medical
We find that our venture capital and private equity clients have a remarkable amount in common with the medtech CTOs and R&D VPs that we work with. Acquiring an innovative technology is often just the start of the journey for our clients. We help maximise post-acquisition ROI by delivering pragmatic solutions to manufacturability, reliability, and cost challenges, creating long lasting value. We understand that value creation can be multi-faceted, and will work to that brief.
Combining technical feasibility based on scientific first principles with strong user insights can deliver exceptional medtech solutions that deliver higher value results. We apply this approach to the build of rapid proof-of-concept demonstrators, providing early feedback and de-risking further investment decisions for both technical and business stakeholders. Our bespoke teams are underpinned by applied science and systems engineering, blending in software, and enhanced strategic and sustainability consulting as required.
We are an end-to-end medical device design consultancy offering advisory and product development services, prototype production, regulatory support, and transfer to manufacture. Our clients include highly innovative start-ups as well as top global medtech companies. With a high customer satisfaction rate and significant repeat business from existing clients we can be relied on to deliver against your desired outcome. Our ISO13485 process builds in a strong focus on user needs, whether that’s a surgeon, a doctor, a nurse, a patient, or their carer.
We find that our venture capital and private equity clients have a remarkable amount in common with the medtech CTOs and R&D VPs that we work with. Acquiring an innovative technology is often just the start of the journey for our clients. We help maximise post-acquisition ROI by delivering pragmatic solutions to manufacturability, reliability, and cost challenges, creating long lasting value. We understand that value creation can be multi-faceted, and will work to that brief.
Combining technical feasibility based on scientific first principles with strong user insights can deliver exceptional medtech solutions that deliver higher value results. We apply this approach to the build of rapid proof-of-concept demonstrators, providing early feedback and de-risking further investment decisions for both technical and business stakeholders. Our bespoke teams are underpinned by applied science and systems engineering, blending in software, and enhanced strategic and sustainability consulting as required.
1/3
What our clients say
“Sagentia Innovation’s work on the thermodynamics was a crucial step in translation of the product from prototype to manufacturing. I appreciated both the excellence of the work and having an external partner to educate our team on the physics.”
Simon J. Archibald, Chief Scientist, Integra LifeSciences
"Sagentia Innovation brought excellent engineering capabilities to our projects, and we have greatly benefitted from our partnership."
Janice Chen, PhD, Co-founder & CTO, Mammoth Biosciences
“Sagentia Innovation brought a highly capable and well-integrated team to the table, along with a very sensible iterative development process. They worked closely with us to develop a differentiated system and enable us to bring the TMINI system to market.”
Joel Zuhars, VP of Research and Development, THINK Surgical
“Bringing advanced optical engineering skills to the table, Sagentia Innovation worked quickly and effectively, driving focused and high-value improvements to the device.”
Philip Hand, Executive Chairman, Intelligent Fingerprinting
“Sagentia Innovation’s work on the thermodynamics was a crucial step in translation of the product from prototype to manufacturing. I appreciated both the excellence of the work and having an external partner to educate our team on the physics.”
Simon J. Archibald, Chief Scientist, Integra LifeSciences
"Sagentia Innovation brought excellent engineering capabilities to our projects, and we have greatly benefitted from our partnership."
Janice Chen, PhD, Co-founder & CTO, Mammoth Biosciences
1 of 4
Follow us
Keep up to date with our news and insights by following us on
Our expertise
Our science and technology teams work cross-sector as we believe that the learnings from one sector can inform another and that clients’ projects should have access to the full range of skills from across the Group.
